PARIS, Sept 19 – Britain’s Oxford Glycosciences (LSE: OGS) announced on Tuesday a deal to buy next generation mass spectrometers from Applied Biosystems (NYSE: PEB) as well as an agreement to collaborate with Packard BioScience (Nasdaq: PBSC) to develop protein biochips.

Financial terms of the deals, which represent significant efforts to secure a leading position in the proteomics sector, were not disclosed.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.